Please use this identifier to cite or link to this item:
Type: Artigo
Title: Diagnostic accuracy of shear wave elastography - virtual touch (TM) imaging quantification in the evaluation of breast masses: impact on ultrasonography's specificity and its ultimate clinical benefit
Author: Doria, Maira Teixeira
Jales, Rodrigo Menezes
Conz, Livia
Mauricette Derchain, Sophie Francoise
Zanatta Sarian, Luis Otavio
Abstract: Objectives: To evaluate the diagnostic performance and the clinical benefit of Shear-Wave Elastography -Virtual Touch T Imaging Quantification (SWE-VTIQ) as a complement to ultrasonography (US). Methods: From October 2016 through Jun 2017, B-mode US and SWE-VTIQ were prospectively performed in 396 breast masses in 357 women who consented to undergo this study. Quantitative elastography values were recorded: V-max (maximum elasticity), Vmean (median elasticity), V-ratio(max) (ratio of V-max and surrounding parenchyma) and Vratio(mean) (ratio of Vmean and surrounding parenchyma). The histopathology of the lesions was considered the reference standard for benign or malignant definition. The performance of the four elastographic parameters was evaluated trough sensitivity, specificity and AUC. The parameter with the best performance was tested in six different diagnostic approaches defined based on clinical practice. Results: Of the 396 masses, 122 (30.8%) were benign and 274 (69.2%) were malignant. All SWE parameters were significantly higher in malignant masses (all p < 0.01). V-max and V-ratio(max) performed significantly better then Vratio(mean) (p=0.01 and p=0.03, respectively). SWE-VTIQ improved US specificity in all diagnostic approaches, except when applied to BI-RADS 3 lesions. SWE-VTIQ reduced the false positive rate in 25% if applied only to BI-RADS 4A masses, maintaining a high sensitivity (98.9%, 95% confidence interval 97.1-100%) and a negative predictive value of 95.5%. When applied to BI-RADS 4A and 4B masses, SWE-VTIQ reduced the false positive rate in 54.4%. However, 13 malignant cases would be missed in this approach (4.7% of all malignant cases). Conclusions: SWE-VTIQ increases US specificity when applied to BI-RADS 4 A lesions, significantly reducing unnecessary interventions and preserving the diagnosis of malignant lesions. When applied also to BI-RADS (R) 4B lesions, SWE-VTIQ increases the number of false negative cases, which should be evaluated with caution.
Subject: Neoplasias da mama
Country: Holanda
Editor: Elsevier
Rights: Fechado
Identifier DOI: 10.1016/j.ejrad.2019.02.004
Date Issue: 2019
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000462586100010.pdf1.2 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.